This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer | MicrobiomeTrials
← Back to trials NCT05009069
A Study of Atezolizumab With or Without Tiragolumab Following Neoadjuvant Chemoradiotherapy in Participants With Locally Advanced Rectal Cancer Recruiting PHASE2 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2022-03-18Est. Completion: 2023-11-21
Enrollment target: 58 participantsLocations Beijing Cancer Hospital, Beijing, China The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China Zhongshan Hospital Fudan University, Shanghai, China First Hospital of China Medical University, Shenyang, China Other microbiome trials you might be interested in Colorectal Neoplasms Neoplasms Intrahepatic Cholangiocarcinoma Adrenocortical Carcinoma Metastasis, Neoplasm
Background:
Cancers that begin in the colon, adrenal glands, or bile ducts may spread to the liver. These liver tumors …
Bethesda, United States Est. completion Dec 31, 2029
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) Non-small Cell Lung Cancer (NSCLC) HR+/HER2- Ductal Breast Cancer (BC)
HR+/HER2- Lobular Breast Cancer (BC)
Triple Negative Breast Cancer (TNBC)
Colorectal Cancer (CRC)
Soft Tissue Sarcoma (STS)
The purpose of Part 1 of this study is to evaluate the imaging characteristics, safety, biodistribution and pharmacokine…
Chuo Ku, Japan Est. completion Jan 16, 2028
Endometrioid Endometrial Cancer
Exploring the therapeutic effect of neoadjuvant chemotherapy combined with PD-1 inhibitor camrelizumab on advanced stage…
Hangzhou, China Est. completion Dec 1, 2027